Thyroid nodules are common, usually asymptomatic, and often pose minimal risk to the
affected patient. However, 10–15% prove malignant and serve as the rationale for …

The incidence of thyroid cancer is on the rise, and this disease is projected to become the
fourth leading type of cancer across the globe. From 1990 to 2013, the global age …

Thyroid nodules are detected in up to 50 to 60% of healthy subjects. Most nodules do not
cause clinically significant symptoms, and as a result, the main challenge in their …

Purpose Understanding secular trends of thyroid cancer is critical to plan strategies for
cancer prevention and control. Our aim was to estimate the incidence and mortality trends of …

Substantial developments have occurred in the past 5–10 years in clinical translational
research of thyroid cancer. Diagnostic molecular markers, such as RET-PTC, RAS, and …

Background: The rapidly rising incidence of papillary thyroid cancer may be due to
overdiagnosis of a reservoir of subclinical disease. To conclude that overdiagnosis is …

Importance Papillary microcarcinomas of the thyroid (mPTCs) account for an increasing
proportion of thyroid cancers in past decades. The use of radiofrequency ablation (RFA) has …

The incidence of differentiated thyroid cancer is increasing greatly in high-income countries.
Roughly 50% of this increase is attributable to the identification of intrathyroidal papillary …

Thyroid cancer incidence has been rising in the United States, and this trend has often been
attributed to heightened medical surveillance and the use of improved diagnostics. Thyroid …

In recent years, the T1799A B-type Raf kinase (BRAF) mutation in thyroid cancer has
received enthusiastic investigation, and significant progress has been made toward …